Cryoport (CYRX) Research & Development (2010 - 2026)

Cryoport (CYRX) has reported Research & Development for 17 consecutive years, with $4.9 million the latest figure, recorded in Q2 2026.

• On a quarterly basis, Research & Development rose 17.82% year-over-year to $4.9 million in Q2 2026; TTM through Jun 2026 was $17.7 million, a 8.46% increase from a year earlier, with the FY2025 full-year figure at $17.0 million, down 3.78% from the prior year.
• Research & Development was $4.9 million for Q2 2026 at Cryoport, up from $3.9 million in the prior quarter.
• Over five years, Research & Development peaked at $5.2 million in Q3 2023 and troughed at $3.5 million in Q2 2022.
• A 5-year average of $4.3 million and a median of $4.2 million in 2023 frame the typical range for Research & Development.
• Across the five-year window, Research & Development retreated 21.07% in 2022 and gained 29.28% in 2023, its largest moves.
• Over 5 years, Research & Development stood at $4.7 million in 2022, then grew by 1.54% to $4.7 million in 2023, then dropped by 12.51% to $4.2 million in 2024, then climbed by 7.48% to $4.5 million in 2025, then rose by 8.64% to $4.9 million in 2026.
• The last three Research & Development figures came in at $4.9 million (Q2 2026), $3.9 million (Q1 2026), and $4.5 million (Q4 2025), per Business Quant data.